4D pharma plc

05/17/2022 | Press release | Distributed by Public on 05/17/2022 00:37

4D pharma Presents Late Breaking Abstract from Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma at the American Thoracic Society (ATS) 2022 International Conference

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.